Article
NMNAT1 and hereditary spastic paraplegia (HSP): expanding the phenotypic spectrum of NMNAT1 variants.
Neuromuscular disorders : NMD - 1 Apr 2023
Sadr Zahra, Ghasemi Aida, Rohani Mohammad, Alavi Afagh
Abstract excerpt
In the NAD biosynthetic network, the nicotinamide mononucleotide adenylyltransferase (NMNAT) enzyme fuels NAD as a co-substrate for a group of enzymes. Mutations in the nuclear-specific isoform, NMNAT1, have been extensively reported as the cause of Leber congenital amaurosis-type 9 (LCA9). However, there are no reports of NMNAT1 mutations causing neurological disorders by disrupting the maintenance of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
